1. Home
  2. ALGS vs YSXT Comparison

ALGS vs YSXT Comparison

Compare ALGS & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • YSXT
  • Stock Information
  • Founded
  • ALGS 2018
  • YSXT 2011
  • Country
  • ALGS United States
  • YSXT China
  • Employees
  • ALGS N/A
  • YSXT N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • YSXT Automotive Aftermarket
  • Sector
  • ALGS Health Care
  • YSXT Consumer Discretionary
  • Exchange
  • ALGS Nasdaq
  • YSXT Nasdaq
  • Market Cap
  • ALGS 56.7M
  • YSXT 58.6M
  • IPO Year
  • ALGS 2020
  • YSXT 2024
  • Fundamental
  • Price
  • ALGS $9.74
  • YSXT $2.22
  • Analyst Decision
  • ALGS Strong Buy
  • YSXT
  • Analyst Count
  • ALGS 2
  • YSXT 0
  • Target Price
  • ALGS $60.00
  • YSXT N/A
  • AVG Volume (30 Days)
  • ALGS 90.2K
  • YSXT 520.7K
  • Earning Date
  • ALGS 11-06-2025
  • YSXT 07-31-2025
  • Dividend Yield
  • ALGS N/A
  • YSXT N/A
  • EPS Growth
  • ALGS N/A
  • YSXT N/A
  • EPS
  • ALGS N/A
  • YSXT 0.18
  • Revenue
  • ALGS $2,646,000.00
  • YSXT $71,452,736.00
  • Revenue This Year
  • ALGS N/A
  • YSXT N/A
  • Revenue Next Year
  • ALGS N/A
  • YSXT N/A
  • P/E Ratio
  • ALGS N/A
  • YSXT $12.70
  • Revenue Growth
  • ALGS N/A
  • YSXT 22.04
  • 52 Week Low
  • ALGS $3.76
  • YSXT $1.68
  • 52 Week High
  • ALGS $46.80
  • YSXT $9.96
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 62.50
  • YSXT 42.21
  • Support Level
  • ALGS $5.81
  • YSXT $1.90
  • Resistance Level
  • ALGS $7.00
  • YSXT $2.34
  • Average True Range (ATR)
  • ALGS 0.79
  • YSXT 0.31
  • MACD
  • ALGS 0.38
  • YSXT -0.03
  • Stochastic Oscillator
  • ALGS 88.61
  • YSXT 25.40

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares

YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.

Share on Social Networks: